Supplementary Materialsfcz052_Supplementary_Data
Supplementary Materialsfcz052_Supplementary_Data. can be improved in cells from leucine-rich do it again kinase 2 pathogenic mutant (G2019S) overexpressing mice, and decreased by leucine-rich do it again kinase 2 inhibitors variously. Somewhere else antisense knock-down of leucine-rich do it again kinase 2 proteins has been proven to safeguard mice from fibril-induced -synuclein aggregation, whereas kinase inhibition…